Document is current
Any future updates will be listed below
-
Authors
Spoelstra, Gerbren B.
Braams, Lisanne M.
IJpma, Frank F. A.
Piersma, Sjouke
Braams, Carolien S.
Bernthal, Nicholas M.
Francis, Kevin P.
Glaudemans, Andor W. J. M.
van Oosten, Marleen
Feringa, Ben L.
Szymanski, Wiktor
Elsinga, Philip H.
van Dijl, Jan Maarten https://orcid.org/0000-0002-5688-8438
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (16895)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (ZonMW grant 91111.006)
- License Information
-
More Information
Article History
Received: 11 February 2026
Accepted: 4 June 2026
First Online: 19 June 2026
Declarations
Ethical approval: All experiments were conducted in accordance with Dutch and EU laws and were performed in the Central Animal Facility of the University of Groningen (Centrale Dienst Dierproeven). Experimental protocols were approved by the National Committee on Animal Experiments of The Netherlands (Centrale Commissie Dierproeven, Den Haag) and the Institutional Animal Care and Use Committee of the University of Groningen (Instantie voor Dierproeven (IvD), CCD license number: AVD10500202114768. IvD licence number: 2114768-01-004).
Consent to participate: Not applicable.
Consent to publish: All authors have agreed with publication of this manuscript.
Competing interests: The authors declare no personal competing interests. However, it should be noticed that funding was in part provided by Stryker European Operations Ltd., and that the project was supported by a user committee of Stryker European Operations Ltd. and Siemens AG. Kevin Francis is a consultant for Bruker Corporation and Philip H. Elsinga is an editor of the European Journal of Nuclear Medicine and Molecular Imaging.
